Precision GTM

Precision GTM™ is a SaaS solution from ConcertAI designed specifically for oncology commercialization teams. It unifies fragmented data sources — including EHR, claims, and social determinants of health (SDOH) — into a single, powerful platform that delivers rich clinical context, near real-time data updates, and built-in generative AI capabilities. Whether teams are preparing for a product launch or tracking patient adherence, Precision GTM bridges the gap between strategy and execution without the delays typically associated with traditional data approaches.

The platform is built for commercial stakeholders across brand leadership, market access, field force and commercial operations, and Medical Science Liaisons (MSLs), enabling each function to act faster, engage more intelligently, and drive measurable outcomes in competitive oncology markets.

Quantifiable Business Impact

• +12 new patients per year: Integrated oncology data enables teams to identify 1–3 additional patients per month, translating insights into immediate commercial value.
• Decision-making 2 months faster: Precision GTM delivers insights up to two months faster than traditional data sources, providing a head start on identifying 40–50 high-value patients.
• 6 fewer months to insights: The platform is deployment-ready, eliminating costly implementation and integration delays that could otherwise result in 30–40 missed patients.
• $2M consulting and reporting value: Teams can perform advanced analytics at zero additional cost, replacing the need for external consultants who might charge $2M for 20 reports or projects.

Core AI-Powered Capabilities

• Cohort Builder Agent: Enables teams to define the right patient populations faster by linking clinical intent, biomarker data, and real-world eligibility in a unified view, supporting precise total addressable market (TAM) sizing and opportunity segmentation.
• Forecast Agent: Provides dynamic insights that adapt as the market evolves, keeping commercial strategies aligned with shifting treatment patterns and market dynamics.
• Access Agent: Pinpoints access barriers, helping market access teams understand and address reimbursement and coverage challenges more effectively.
• Persona Agent: Delivers deep prescriber intelligence, enabling field teams and MSLs to understand HCP behavior and preferences at an unprecedented level of detail.

Commercial Team Use Cases

• Brand Lead: Leverages platform insights to lead strategy, grow brand performance, and strengthen market presence and perception.
• Market Access: Uses access and coverage data to negotiate with payers and PBMs, securing favorable pricing, reimbursement, and formulary placement.
• Field Force and Commercial Operations: Optimizes the systems and processes that power sales and marketing execution across the commercial organization.
• Medical Science Liaisons (MSLs): Engages healthcare providers with evidence-based, non-promotional medical education informed by real-world clinical data.

Market Intelligence and Treatment Insights

• Delivers real-time insights into treatment patterns, market dynamics, and care gaps across oncology therapeutic areas.
• Empowers commercial teams to move from strategy to execution without lag, leveraging one of the industry's largest oncology datasets for unmatched exploration and discovery.
• Supports TAM quantification and opportunity segmentation by combining clinical intent signals, biomarker data, and real-world patient eligibility in a single unified view.

Precision GTM is offered as an out-of-the-box, deployment-ready SaaS solution under ConcertAI's broader Precision Suite of commercial products. Its built-in GenAI agents and integrated oncology data infrastructure eliminate the need for lengthy implementation cycles or costly third-party consulting engagements, making it well-suited for oncology commercial teams seeking rapid time-to-insight and scalable analytics capabilities.